LON:COG Cambridge Cognition (COG) Share Price, News & Analysis GBX 46.50 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range 45.27▼ 4850-Day Range 38▼ 46.4452-Week Range 37▼ 99.60Volume6,228 shsAverage Volume55,235 shsMarket Capitalization£19.50 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Cambridge Cognition alerts: Email Address Ad Weiss RatingsWhat is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. About Cambridge Cognition Stock (LON:COG)Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency. It also provides CANTAB Connect Research, a proprietary platform that provides insights into behaviours, underlying brain circuits, and measurement of digital cognitive biomarkers; CANTAB Mobile, a touchscreen assessment of memory, mood, and functional status to detect the earliest signs of clinically relevant memory problems; CANTAB Insight to assess cognitive health; and CANTAB BrainHealth for assessing workplace wellbeing. In addition, the company offers electronic questionnaires and scales, a digital bespoke questionnaire; NeuroVocalix, a voice analysis platform to analyze voice to assess neurological change; cognition kit, a high frequency testing kit to detect changes over time and day-to-day cognition with short regular tests using patients' own devices. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.Read More COG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart COG Stock News HeadlinesSeptember 7 at 9:00 AM | msn.comStudy identifies five different ways of aging thanks to data from 50,000 brain scansSeptember 6 at 5:56 PM | finance.yahoo.comSplash Clinical Announces Partnership with Cambridge CognitionSeptember 7, 2024 | Weiss Ratings (Ad)What is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …September 6 at 1:18 AM | bbc.co.ukWalking, cycling to school more likely in Ulez - reportSeptember 5 at 10:14 AM | msn.comULEZ has cut children's school car rides - studySeptember 2, 2024 | msn.comOpinion: Reading is the best gift you can give a childAugust 31, 2024 | msn.comDoctor Reveals Surprising Thing That Occurs When You Don't Eat – and It's The ‘Opposite' of What Most People ThinkAugust 30, 2024 | msn.comBeloved mum received worrying health diagnosis after assuming she was just stressedSeptember 7, 2024 | Weiss Ratings (Ad)What is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …August 28, 2024 | msn.comPrimary care providers urged to assist patients who engage in emotional eatingAugust 23, 2024 | lse.co.ukCambridge Cognition narrows loss and slashes costs in first halfAugust 21, 2024 | msn.comHidden Consciousness Exists in Humans—So Much More Than We Thought, Scientists SayAugust 16, 2024 | msn.comUK’s largest study of children’s mental health treatment launched by Cambridgeshire health trustAugust 15, 2024 | nytimes.comUnresponsive Brain-Damaged Patients May Have Some AwarenessAugust 14, 2024 | msn.comThe warning sign for Alzheimer’s that happens years before other symptomsAugust 12, 2024 | msn.comWoodstock revisited: whatever happened to the hippie dream?August 8, 2024 | yahoo.com19 Olympic Athletes Whose College Degrees Have Nothing To Do With SportsAugust 6, 2024 | msn.comIt is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchersSee More Headlines Receive COG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cambridge Cognition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/22/2020Today9/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolLON:COG CUSIPN/A CIKN/A Webwww.cambridgecognition.com Phone44 1223 810 700FaxN/AEmployees80Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.04) Trailing P/E RatioN/A Forward P/E Ratio42.35 P/E GrowthN/ANet Income£-1,320,000.00 Net Margins-10.07% Pretax MarginN/A Return on Equity-74.36% Return on Assets-0.30% Debt Debt-to-Equity Ratio92.53 Current Ratio0.65 Quick Ratio0.96 Sales & Book Value Annual Sales£13.08 million Price / Sales1.49 Cash FlowGBX 10.80 per share Price / Cash Flow4.31 Book ValueGBX 6 per share Price / Book7.75Miscellaneous Outstanding Shares41,940,000Free FloatN/AMarket Cap£19.50 million OptionableNot Optionable Beta0.72 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Matthew William Stork (Age 56)CEO & Director Comp: $342kMr. Stephen Daniel Symonds (Age 48)CFO & Executive Director Comp: $203.31kMr. John HammondCo-FounderMr. Nick TaptiklisHead of Technology StrategyMs. Francesca Cormack Ph.D.Chief Scientist & Member of Scientific Advisory BoardMr. Simon MerrittMarketing and Communications DirectorDr. Lisa Elizabeth Nolan Ph.D. (Age 62)Vice President Business Development Ms. Nicky AckerleyGlobal HR DirectorProf. Trevor Robbins CBEFBPsS, FMedSci, FRS, Ph.D., Senior ConsultantProf. Barbara Sahakian FBPsSFMedSci, Senior ConsultantMore ExecutivesKey CompetitorsRenalytixLON:RENXInduction Healthcare GroupLON:INHCFeedbackLON:FDBKIQ-AILON:IQAITrellus HealthLON:TRLSView All Competitors COG Stock Analysis - Frequently Asked Questions How have COG shares performed this year? Cambridge Cognition's stock was trading at GBX 51.50 on January 1st, 2024. Since then, COG shares have decreased by 9.7% and is now trading at GBX 46.50. View the best growth stocks for 2024 here. How were Cambridge Cognition's earnings last quarter? Cambridge Cognition Holdings Plc (LON:COG) posted its earnings results on Tuesday, September, 22nd. The company reported ($1.50) EPS for the quarter. Cambridge Cognition had a negative net margin of 10.07% and a negative trailing twelve-month return on equity of 74.36%. How do I buy shares of Cambridge Cognition? Shares of COG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Cambridge Cognition own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cambridge Cognition investors own include Interserve (IRV), Alio Gold Inc. (ALO.TO) (ALO), Concepta PLC (CPT.L) (CPT), European Metals (EMH), IntelGenx Technologies (IGXT), Oxford Biomedica (OXB) and Syneos Health (SYNH). This page (LON:COG) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Cognition Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambridge Cognition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.